ALPS Medical Breakthroughs ETF
SBIO
#2468
ETF rank
โ‚ฌ0.16 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
47,97ย โ‚ฌ
Share price
0.39%
Change (1 day)
25.82%
Change (1 year)

Expense ratio and fees for ALPS Medical Breakthroughs ETF (SBIO)

Gross Expense Ratio

Gross Expense Ratio as of November 2026: 0.5%

Net Expense Ratio

Net Expense Ratio as of November 2026: 0.5%